Scott, Bart L <br/><br/>
Myeloablative Versus Reduced-Intensity Hematopoietic Cell Transplantation for Acute Myeloid Leukemia and Myelodysplastic Syndromes.  [electronic resource] 

 -  Journal of clinical oncology : official journal of the American Society of Clinical Oncology  Apr 2017 
 - 1154-1161 p.  digital 
<br/><br/> Publication Type: Clinical Trial, Phase III; Comparative Study; Journal Article; Randomized Controlled Trial 
<br/><br/><label>ISSN: </label>1527-7755 
<br/><br/><label>Standard No.: </label>10.1200/JCO.2016.70.7091  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Aged<br/>Antineoplastic Combined Chemotherapy Protocols--therapeutic use<br/>Busulfan--administration & dosage<br/>Cause of Death<br/>Cyclosporine--administration & dosage<br/>Disease-Free Survival<br/>Female<br/>Graft vs Host Disease--etiology<br/>Hematopoietic Stem Cell Transplantation--adverse effects<br/>Humans<br/>Immunosuppressive Agents--therapeutic use<br/>Kaplan-Meier Estimate<br/>Leukemia, Myeloid, Acute--therapy<br/>Male<br/>Melphalan--administration & dosage<br/>Middle Aged<br/>Myelodysplastic Syndromes--therapy<br/>Recurrence<br/>Survival Rate<br/>Transplantation Conditioning--adverse effects<br/>Transplantation, Homologous<br/>Vidarabine--administration & dosage<br/>Whole-Body Irradiation<br/>Young Adult